课题基金 / 基金详情

CLINICAL TRIAL: MRK AD5 HIV-1 GAG VACCINE IN HIV-1 SUBJECTS WHO INTERUPT THERAPY

CLINICAL TRIAL: MRK AD5 HIV-1 GAG VACCINE IN HIV-1 SUBJECTS WHO INTERUPT THERAPY
临床试验：在中断治疗的 HIV-1 受试者中使用 MRK AD5 HIV-1 GAG 疫苗
批准号：
7716792
负责人：
DAVID A WOHL
金额：
$1.34万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-04-02 至 2008-05-31
来源：
https://reporter.nih.gov/project-details/7716792
关键词：
Anti-HIV AgentsClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseFundingGaggingGrantHIVHIV vaccineInstitutionPlacebosResearchResearch PersonnelResourcesSourceUnited States National Institutes of HealthVaccinesViral Load result

项目摘要

项目成果

DAVID A WOHL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will compare the HIV viral load of people off anti-HIV drugs who have either received an HIV-vaccine or a vaccine placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION
海外基金